Nilgün Kizilmese
Biographic Data
| ID | 6786186 |
|---|---|
| NAME | Nilgün Kizilmese |
| GIVEN NAMES | Nilgün |
| FAMILY NAME | Kizilmese |
| SIGNATURE | KIZILMESE N |
| AFFILIATIONS | Province of Antwerp |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Optimization of the (pharmacotherapeutic) treatment and care of the diabetes type 2 patient in Belgium through multidisciplinary collaboration between general practitioner and community pharmacist
Introduction: Diabetes type 2 is a chronic condition that can lead to devastating micro-and/or macrovascular complications in the long term when not treated properly. This causes decreased health-related quality of life and an increased risk for morbidity and mortality. Despite safe and effective drugs, there are major challenges in the treatment of diabetes type 2: (1) medication adherence, (2) optimizing pharmacotherapy, (3) non-pharmacotherapy…
What role do professional management organizations play in the implementation of Medical-Pharmaceutical Concertation in Belgium
Introduction: Inadequate use of medication (e.g. over-under-or misuse, interactions, wrong dosing...) can lead to potential clinical dangerous situations. Therefore, the risk need to be mitigated. In 2015, the National Institute for Health & Disability Insurance (NIHDI) of Belgium has created a legal and financial framework (Medical-Pharmaceutical Concertation (MPC) to promote and facilitate local concertation between general practitioners (GP) a…
No prominent works on this page.
Optimization of the (pharmacotherapeutic) treatment and care of the diabetes type 2 patient in Belgium through multidisciplinary collaboration between general practitioner and community pharmacist
Introduction: Diabetes type 2 is a chronic condition that can lead to devastating micro-and/or macrovascular complications in the long term when not treated properly. This causes decreased health-related quality of life and an increased risk for morbidity and mortality. Despite safe and effective drugs, there are major challenges in the treatment of diabetes type 2: (1) medication adherence, (2) optimizing pharmacotherapy, (3) non-pharmacotherapy…
What role do professional management organizations play in the implementation of Medical-Pharmaceutical Concertation in Belgium
Introduction: Inadequate use of medication (e.g. over-under-or misuse, interactions, wrong dosing...) can lead to potential clinical dangerous situations. Therefore, the risk need to be mitigated. In 2015, the National Institute for Health & Disability Insurance (NIHDI) of Belgium has created a legal and financial framework (Medical-Pharmaceutical Concertation (MPC) to promote and facilitate local concertation between general practitioners (GP) a…
Context (archaeology (2 works) · Medicine (2 works) · Nursing (2 works) · Pharmaceutical Practices and Patient Outcomes (2 works) · Political science (2 works) · Business (1 work) · Clinical practice guidelines implementation (1 work) · Diabetes Management and Education (1 work) · Diabetes mellitus (1 work) · Economics (1 work)